Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pregnancy Outcomes in Multiple Sclerosis Populations Exposed and Unexposed to Interferon β - a Register-based Study in the Nordic Countries

NCT02749396 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT02749396
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02749396 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pregnancy Outcomes in Multiple Sclerosis Populations Exposed and Unexposed to Interferon β - a Register-based Study in the Nordic Countries
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
May 2, 2016
Completion date
August 14, 2018
Enrollment
2,089 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis